Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position

被引:12
|
作者
Nkiwane, Karen S. [1 ]
Poetter, Richard [1 ]
Fokdal, Lars U. [2 ]
Hoskin, Peter [3 ]
Pearcey, Robert [4 ]
Segedin, Barbara [5 ]
Mahantshetty, Umesh [6 ]
Kirisits, Christian [1 ]
机构
[1] Med Univ Vienna, Ctr Comprehens Canc, Dept Radiotherapy, A-1090 Vienna, Austria
[2] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
[3] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England
[4] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[5] Inst Oncol Ljubljana, Dept Oncol, Ljubljana, Slovenia
[6] Tata Mem Hosp, Dept Radiat Oncol, Mumbai 400012, Maharashtra, India
基金
奥地利科学基金会;
关键词
Brachytherapy; Cervical cancer; 3D MRI; Bladder D-2cc; Applicator position; IMAGE-GUIDED BRACHYTHERAPY; INTRACAVITARY BRACHYTHERAPY; VOLUME PARAMETERS; ADAPTIVE BRACHYTHERAPY; RECOMMENDATIONS; RADIOTHERAPY; RECTUM; DISTENSION; CARCINOMA; PATTERNS;
D O I
10.1016/j.brachy.2014.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: To validate the feasibility and use of dose points to characterize the bladder wall dose distribution and investigate potential impact of the applicator position in cervical cancer brachytherapy. METHODS AND MATERIALS: One hundred twenty-eight optimized MRI plans were evaluated. The International Commission of Radiation Units and Measurements (ICRU-38) point doses (Brow), surrogate for bladder base doses, were compared with D-2cc. Vaginal source to superior-anterior border of the symphysis distances were measured and compared within two groups, namely Group 1-B-ICRU/D-2cc >= 1 and Group 2-B-ICRU/D-2cc <1. Additionally, points at 1.5 and 2 cm cranial to the B-ICRU, parallel to the tandem and the body axis were analyzed. RESULTS: Thirty-seven percent of the patients had the ratio B-ICRU/D-2cc of 1 or higher, with the 2cc subvolume at the bladder base (Group 1). In 63%, B-ICRU/D-2cc, ratio was lower than 1 and the 2cc, cranial to the bladder base (Group 2). Median vaginal source-to-superior anterior border of the symphysis line distance was -2 cm (range, -3.7 to + 1.2 cm) in Group 1 and +1.8 cm (range, -2 to +4.8 cm) in Group 2 (+ cranial/- caudal direction). There was a high correlation between vaginal sources near the symphysis and the 2cc subvolume at the bladder base. The additional points provided no added value. CONCLUSIONS: Location of the 2cc subvolume varies in cervical cancer brachytherapy. Maximum doses are at the bladder base if vaginal sources are also in the vicinity of the bladder base indicated by B-ICRU/D-2cc ratio of 1 or higher. Such variation should be considered in dose-effect analyses and intercomparisons, as the same D-2cc at different bladder locations may correlate with different morbidity profiles and severity Reporting D-2cc and B-ICRU doses together therefore remains essential. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 50 条
  • [1] Bladder Dose in Gynecological Brachytherapy by Using Orthogonal Radiographs: Late Effects and Posterior Bladder Wall Dose
    Pinezi, J. C.
    Cintra, H. S.
    Passos, D. A. C.
    Costa, T. R.
    Simon, P. A.
    Senna, M. T.
    Machado, G. D. P.
    Soares, R. B. A.
    Carvalho, H. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S718 - S719
  • [2] Study of positional dependence of dose to bladder, pelvic wall and rectal points in High-Dose-Rate Brachytherapy in cervical cancer patients
    Talluri, Anil Kumar
    Alluri, Krishnam Raju
    Gudipudi, Deleep Kumar
    Ahamed, Shabbir
    Sresty, Madhusudhana M.
    Reddy, Aparna Yarrama
    JOURNAL OF MEDICAL PHYSICS, 2013, 38 (04) : 178 - 184
  • [3] THE IMPACT OF BLADDER VOLUME ON BLADDER DOSE AND TARGET COVERAGE FOR MRI BASED INTRAUTERINE BRACHYTHERAPY FOR INVASIVE CERVICAL CANCER
    Tse, V.
    Thewlis, N.
    Aldridge, S. E.
    Naeem, M.
    Bozic, N.
    Jones, E.
    Mullassery, V.
    Winship, A. Z.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [4] Bladder dose distribution in cylindrical brachytherapy treatment
    Xiong, L.
    Viswanathan, A.
    Stewart, A.
    Cormack, R.
    MEDICAL PHYSICS, 2006, 33 (06) : 2074 - 2074
  • [5] MRI-guided brachytherapy for cervical cancer treatment: The significance of bladder morphology in dose distribution planning
    Choi, Euncheol
    Kim, Byungyong
    Byun, Sang Jun
    Kim, Jin Hee
    Park, Seung Gyu
    Kim, Myeongsoo
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2024, 16 (03) : 184 - 192
  • [6] LATE EFFECTS ON RECTUM AND URINARY BLADDER IN CERVICAL CANCER BRACHYTHERAPY: DOSE EFFECT RELATIONSHIP AND ICRU RECTUM AND BLADDER POINT DOSE CORRELATION
    Mathews, S.
    Balachandran, H.
    Kumar, A.
    Joseph, J.
    Kumar, R.
    Krishna, J.
    James, F. V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A75 - A75
  • [7] Association of bladder dose with late urinary side effects in cervical cancer high-dose-rate brachytherapy
    Zakariaee, Roja
    Hamarneh, Ghassan
    Brown, Colin J.
    Gaudet, Marc
    Aquino-Parsons, Christina
    Spadinger, Ingrid
    BRACHYTHERAPY, 2017, 16 (06) : 1175 - 1183
  • [8] Brachytherapy Treatment Planning and Linac for Dose Measurement of Bladder and Rectum in Cervical Cancer Patients
    Astuti, Suryani Dyah
    Listya, Gege Ayu
    Fitriyah, Nurul
    Suhartono, Bambang Haris
    2018 3RD INTERNATIONAL SEMINAR ON SENSORS, INSTRUMENTATION, MEASUREMENT AND METROLOGY (ISSIMM), 2018, : 7 - 10
  • [9] Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy
    Raleigh, David R.
    Hsu, I-Chow
    Braunstein, Steve
    Chang, Albert J.
    Simko, Jeffry P.
    Roach, Mack, III
    BRACHYTHERAPY, 2015, 14 (02) : 185 - 188
  • [10] DOSE PAINTING IN HDR BRACHYTHERAPY FOR CERVIX CANCER: IMPACT OF BLADDER VOLUME VARIATION ON THE HIGHEST DOSE POINT
    Bachand, F.
    Lim, P.
    Dubash, R.
    Yuen, C.
    Hong, W.
    Aquino-Parsons, C.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S25 - S25